<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00959660</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00005668</org_study_id>
    <secondary_id>R37AG018915</secondary_id>
    <nct_id>NCT00959660</nct_id>
  </id_info>
  <brief_title>Exercise Intolerance in Elderly Patients With Diastolic Heart Failure</brief_title>
  <acronym>SECRET</acronym>
  <official_title>Study of the Effect of Caloric Restriction and Exercise Training in Patients With Heart Failure and a Normal Ejection Fraction.(SECRET)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Wake Forest University Health Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the effects of weight loss via hypocaloric diet,
      aerobic exercise training, combined hypocaloric diet and exercise training, and attention
      control in patients with heart failure and a normal ejection fraction (HFNEF) and body mass
      index greater than or equal to 30.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Heart failure with a normal ejection fraction (HFNEF, previously termed diastolic heart
      failure), accounts for the majority of heart failure cases in the population &gt; 65 years old
      and has been recognized as a true geriatric syndrome. Exercise intolerance is the primary
      chronic symptom of HFNEF and a major determinant of these patients' severely reduced quality
      of life; however little is known regarding its pathophysiology and treatment. Therefore, our
      work has focused on understanding the pathophysiology of exercise intolerance in HFNEF and
      developing and testing interventions that may improve this pivotal outcome in this highly
      prevalent disorder of older persons. The aims of the proposed study are to conduct a
      randomized, controlled, single-blinded, 2x2 design trial to examine the effects of weight
      loss via hypocaloric diet, aerobic exercise training, combined hypocaloric diet and exercise
      training, and attention control in patients with HFNEF and body mass index &gt;30 in order to
      test the following hypotheses: 1) Both weight loss and exercise training will improve
      exercise intolerance and quality of life in older, obese patients with HFNEF; 2) The
      combination of weight loss and exercise training will produce complementary effects on body
      and thigh muscle composition and additive improvements in exercise intolerance in HFNEF; 3)
      Improvements in exercise intolerance will correlate with improvements in lean body mass,
      reversal of adverse thigh muscle remodeling, and increased thigh muscle capillarity. The
      study has the potential to significantly advance our understanding of exercise intolerance
      and its treatment in the large population of older persons with HFNEF.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 2009</start_date>
  <completion_date type="Actual">August 2013</completion_date>
  <primary_completion_date type="Actual">August 15, 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exercise Capacity</measure>
    <time_frame>20 weeks</time_frame>
    <description>Exercise capacity assessed as Peak VO2 (ml/kg/min) via treadmill cardiopulmonary exercise testing using the modified Naughton protocol to the end point of exhaustion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life</measure>
    <time_frame>20 weeks</time_frame>
    <description>Heart failure-specific quality of life was assessed with the Kansas City Cardiomyopathy Questionnaire (KCCQ) on a range 0-100; higher scores indicate better quality of life.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Composition</measure>
    <time_frame>20 weeks</time_frame>
    <description>Total Body Fat Mass and Total Non-bone Lean Mass via DEXA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Thigh Muscle Composition</measure>
    <time_frame>20 weeks</time_frame>
    <description>Thigh Skeletal Muscle and Subcutaneous Fat via MRI</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Heart Failure, Diastolic</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Exercise Training</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exercise participants will undergo a 1-hour supervised exercise program 3 times per week for 20 weeks consisting primarily of walking exercise using an individualized exercise prescription based on the initial exercise stress testing results.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dietary Intervention</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb) weight loss per week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Attention control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Attention control participants will be provided a counseling session regarding general health education at baseline and will be contacted by staff via telephone every 2 weeks to discuss general health status.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Diet and Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A hypocaloric diet will be developed to achieve a 2450 kcal/week deficit in addition to undergoing a 1-hour supervised exercise program 3 times per week for 20 weeks consisting primarily of walking exercise using an individualized exercise prescription based on the initial exercise stress testing results.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>walking, treadmill and bicycle exercise</description>
    <arm_group_label>Exercise Training</arm_group_label>
    <arm_group_label>Diet and Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary Intervention</intervention_name>
    <description>Subjects will be provided meals and instructions for individual food selections.</description>
    <arm_group_label>Dietary Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diet and exercise</intervention_name>
    <description>Subjects will be provided meals and instructions for individual food selections and will undergo walking, treadmill and bicycle exercise.</description>
    <arm_group_label>Diet and Exercise</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Attention Control</intervention_name>
    <description>control group- continue their previously randomized life style</description>
    <arm_group_label>Attention control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Heart failure clinical score greater than or equal to 3

          -  Age 60 and over

          -  Normal ejection fraction greater than or equal to 50%

          -  BMI greater than or equal to 30

        Exclusion Criteria:

          -  Valvular heart disease

          -  Significant change in cardiac medication &lt;4 weeks

          -  Uncontrolled hypertension

          -  Recent or debilitating stroke

          -  Cancer or other noncardiovascular conditions with life expectancy less than 2 years

          -  Significant Anemia

          -  Renal insufficiency (creatinine &gt;2.5mg/dl)

          -  Psychiatric disease- uncontrolled major psychoses, depressions, dementia, or
             personality disorder

          -  Plans to leave area within 6 months

          -  Refuses informed consent

          -  Failure to pass screening test:pulmonary function, echocardiogram,or exercise
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dalane W Kitzman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wake Forest University Health Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wake Forest University Health Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>271757</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2009</study_first_submitted>
  <study_first_submitted_qc>August 14, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 17, 2009</study_first_posted>
  <results_first_submitted>January 26, 2018</results_first_submitted>
  <results_first_submitted_qc>March 13, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">April 11, 2018</results_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diastolic heart failure</keyword>
  <keyword>Heart Failure</keyword>
  <keyword>Elderly</keyword>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Failure, Diastolic</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Exercise Training</title>
          <description>Based on initial evaluations and the stress testing results, (HR(heart rate), VO2(maximal volume of oxygen that the body can deliver to the working muscles per minute), RPE(rate perceived exertion) an individualized exercise prescription will be developed for each subject.
Exercise: walking, treadmill and bicycle exercise</description>
        </group>
        <group group_id="P2">
          <title>Dietary Intervention</title>
          <description>A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb) weight loss per week.
Dietary Intervention: Subjects will be provided meals and instructions for individual food selections.</description>
        </group>
        <group group_id="P3">
          <title>Attention Control</title>
          <description>Attention control participants will be provided a counseling session regarding general health education at baseline and will be contacted by staff via telephone every 2 weeks to discuss general health status.
Attention Control: control group- continue their previously randomized life style</description>
        </group>
        <group group_id="P4">
          <title>Diet and Exercise</title>
          <description>The diet and exercise group is a combination of the two groups previously described.
Exercise: walking, treadmill and bicycle exercise
Diet and exercise: Combination of the exercise and diet group as previously described.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="25"/>
                <participants group_id="P4" count="25"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
                <participants group_id="P2" count="24"/>
                <participants group_id="P3" count="22"/>
                <participants group_id="P4" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="3"/>
                <participants group_id="P4" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Exercise Training</title>
          <description>Based on initial evaluations and the stress testing results, (HR(heart rate), VO2(maximal volume of oxygen that the body can deliver to the working muscles per minute), RPE(rate perceived exertion) an individualized exercise prescription will be developed for each subject.
Exercise: walking, treadmill and bicycle exercise</description>
        </group>
        <group group_id="B2">
          <title>Dietary Intervention</title>
          <description>A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb) weight loss per week.
Dietary Intervention: Subjects will be provided meals and instructions for individual food selections.</description>
        </group>
        <group group_id="B3">
          <title>Attention Control</title>
          <description>Attention control participants will be provided a counseling session regarding general health education at baseline and will be contacted by staff via telephone every 2 weeks to discuss general health status.
Attention Control: control group- continue their previously randomized life style</description>
        </group>
        <group group_id="B4">
          <title>Diet and Exercise</title>
          <description>The diet and exercise group is a combination of the two groups previously described.
Exercise: walking, treadmill and bicycle exercise
Diet and exercise: Combination of the exercise and diet group as previously described.</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
            <count group_id="B2" value="24"/>
            <count group_id="B3" value="25"/>
            <count group_id="B4" value="25"/>
            <count group_id="B5" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67.5" spread="5.9"/>
                    <measurement group_id="B2" value="66.5" spread="4.9"/>
                    <measurement group_id="B3" value="65.6" spread="4.8"/>
                    <measurement group_id="B4" value="66.3" spread="5.2"/>
                    <measurement group_id="B5" value="66.5" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="20"/>
                    <measurement group_id="B5" value="81"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="5"/>
                    <measurement group_id="B4" value="5"/>
                    <measurement group_id="B5" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="12"/>
                    <measurement group_id="B5" value="45"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="16"/>
                    <measurement group_id="B4" value="13"/>
                    <measurement group_id="B5" value="55"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Exercise Capacity</title>
        <description>Exercise capacity assessed as Peak VO2 (ml/kg/min) via treadmill cardiopulmonary exercise testing using the modified Naughton protocol to the end point of exhaustion.</description>
        <time_frame>20 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Training</title>
            <description>Based on initial evaluations and the stress testing results, (HR(heart rate), VO2(maximal volume of oxygen that the body can deliver to the working muscles per minute), RPE(rate perceived exertion) an individualized exercise prescription will be developed for each subject.
Exercise: walking, treadmill and bicycle exercise</description>
          </group>
          <group group_id="O2">
            <title>Dietary Intervention</title>
            <description>A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb) weight loss per week.
Dietary Intervention: Subjects will be provided meals and instructions for individual food selections.</description>
          </group>
          <group group_id="O3">
            <title>Attention Control</title>
            <description>Attention control participants will be provided a counseling session regarding general health education at baseline and will be contacted by staff via telephone every 2 weeks to discuss general health status.
Attention Control: control group- continue their previously randomized life style</description>
          </group>
          <group group_id="O4">
            <title>Diet and Exercise</title>
            <description>The diet and exercise group is a combination of the two groups previously described.
Exercise: walking, treadmill and bicycle exercise
Diet and exercise: Combination of the exercise and diet group as previously described.</description>
          </group>
        </group_list>
        <measure>
          <title>Exercise Capacity</title>
          <description>Exercise capacity assessed as Peak VO2 (ml/kg/min) via treadmill cardiopulmonary exercise testing using the modified Naughton protocol to the end point of exhaustion.</description>
          <units>ml/kg/min</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15.5" lower_limit="15.1" upper_limit="15.9"/>
                    <measurement group_id="O2" value="15.5" lower_limit="15.1" upper_limit="15.9"/>
                    <measurement group_id="O3" value="14.1" lower_limit="13.5" upper_limit="14.7"/>
                    <measurement group_id="O4" value="16.6" lower_limit="16.0" upper_limit="17.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Main effects analysis with Diet vs. No Diet.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Main effects analysis with Exercise vs. No Exercise.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quality of Life</title>
        <description>Heart failure-specific quality of life was assessed with the Kansas City Cardiomyopathy Questionnaire (KCCQ) on a range 0-100; higher scores indicate better quality of life.</description>
        <time_frame>20 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Training</title>
            <description>Based on initial evaluations and the stress testing results, (HR(heart rate), VO2(maximal volume of oxygen that the body can deliver to the working muscles per minute), RPE(rate perceived exertion) an individualized exercise prescription will be developed for each subject.
Exercise: walking, treadmill and bicycle exercise</description>
          </group>
          <group group_id="O2">
            <title>Dietary Intervention</title>
            <description>A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb) weight loss per week.
Dietary Intervention: Subjects will be provided meals and instructions for individual food selections.</description>
          </group>
          <group group_id="O3">
            <title>Attention Control</title>
            <description>Attention control participants will be provided a counseling session regarding general health education at baseline and will be contacted by staff via telephone every 2 weeks to discuss general health status.
Attention Control: control group- continue their previously randomized life style</description>
          </group>
          <group group_id="O4">
            <title>Diet and Exercise</title>
            <description>The diet and exercise group is a combination of the two groups previously described.
Exercise: walking, treadmill and bicycle exercise
Diet and exercise: Combination of the exercise and diet group as previously described.</description>
          </group>
        </group_list>
        <measure>
          <title>Quality of Life</title>
          <description>Heart failure-specific quality of life was assessed with the Kansas City Cardiomyopathy Questionnaire (KCCQ) on a range 0-100; higher scores indicate better quality of life.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71" lower_limit="67" upper_limit="75"/>
                    <measurement group_id="O2" value="77" lower_limit="73" upper_limit="81"/>
                    <measurement group_id="O3" value="69" lower_limit="63" upper_limit="75"/>
                    <measurement group_id="O4" value="79" lower_limit="75" upper_limit="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.004</p_value>
            <p_value_desc>Main effects analyses with Diet vs. No Diet.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.43</p_value>
            <p_value_desc>Main effects analysis for Exercise vs. No Exercise.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Composition</title>
        <description>Total Body Fat Mass and Total Non-bone Lean Mass via DEXA</description>
        <time_frame>20 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Training</title>
            <description>Based on initial evaluations and the stress testing results, (HR(heart rate), VO2(maximal volume of oxygen that the body can deliver to the working muscles per minute), RPE(rate perceived exertion) an individualized exercise prescription will be developed for each subject.
Exercise: walking, treadmill and bicycle exercise</description>
          </group>
          <group group_id="O2">
            <title>Dietary Intervention</title>
            <description>A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb) weight loss per week.
Dietary Intervention: Subjects will be provided meals and instructions for individual food selections.</description>
          </group>
          <group group_id="O3">
            <title>Attention Control</title>
            <description>Attention control participants will be provided a counseling session regarding general health education at baseline and will be contacted by staff via telephone every 2 weeks to discuss general health status.
Attention Control: control group- continue their previously randomized life style</description>
          </group>
          <group group_id="O4">
            <title>Diet and Exercise</title>
            <description>The diet and exercise group is a combination of the two groups previously described.
Exercise: walking, treadmill and bicycle exercise
Diet and exercise: Combination of the exercise and diet group as previously described.</description>
          </group>
        </group_list>
        <measure>
          <title>Body Composition</title>
          <description>Total Body Fat Mass and Total Non-bone Lean Mass via DEXA</description>
          <units>kg</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Total Fat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45" lower_limit="43" upper_limit="47"/>
                    <measurement group_id="O2" value="42" lower_limit="40" upper_limit="44"/>
                    <measurement group_id="O3" value="47" lower_limit="45" upper_limit="49"/>
                    <measurement group_id="O4" value="40" lower_limit="38" upper_limit="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Total Non-Bone Lean</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52" lower_limit="50" upper_limit="54"/>
                    <measurement group_id="O2" value="50" lower_limit="50" upper_limit="50"/>
                    <measurement group_id="O3" value="53" lower_limit="53" upper_limit="53"/>
                    <measurement group_id="O4" value="50" lower_limit="48" upper_limit="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Total Body Fat Mass</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Main effects analyses with Diet vs. No Diet.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Total Body Fat Mass</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.001</p_value>
            <p_value_desc>Main effects analysis of Exercise vs. No Exercise.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Total Non-Bone Lean Mass</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Main effects analyses with Diet vs. No Diet.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Total Non-Bone Lean Mass</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.25</p_value>
            <p_value_desc>Main effects analysis for Exercise vs. No Exercise.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Thigh Muscle Composition</title>
        <description>Thigh Skeletal Muscle and Subcutaneous Fat via MRI</description>
        <time_frame>20 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Exercise Training</title>
            <description>Based on initial evaluations and the stress testing results, (HR(heart rate), VO2(maximal volume of oxygen that the body can deliver to the working muscles per minute), RPE(rate perceived exertion) an individualized exercise prescription will be developed for each subject.
Exercise: walking, treadmill and bicycle exercise</description>
          </group>
          <group group_id="O2">
            <title>Dietary Intervention</title>
            <description>A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb) weight loss per week.
Dietary Intervention: Subjects will be provided meals and instructions for individual food selections.</description>
          </group>
          <group group_id="O3">
            <title>Attention Control</title>
            <description>Attention control participants will be provided a counseling session regarding general health education at baseline and will be contacted by staff via telephone every 2 weeks to discuss general health status.
Attention Control: control group- continue their previously randomized life style</description>
          </group>
          <group group_id="O4">
            <title>Diet and Exercise</title>
            <description>The diet and exercise group is a combination of the two groups previously described.
Exercise: walking, treadmill and bicycle exercise
Diet and exercise: Combination of the exercise and diet group as previously described.</description>
          </group>
        </group_list>
        <measure>
          <title>Thigh Muscle Composition</title>
          <description>Thigh Skeletal Muscle and Subcutaneous Fat via MRI</description>
          <units>cm^2</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
                <count group_id="O3" value="22"/>
                <count group_id="O4" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Thigh Subcutaneous Fat</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="155" lower_limit="149" upper_limit="161"/>
                    <measurement group_id="O2" value="143" lower_limit="137" upper_limit="149"/>
                    <measurement group_id="O3" value="164" lower_limit="158" upper_limit="170"/>
                    <measurement group_id="O4" value="144" lower_limit="138" upper_limit="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thigh Skeletal Muscle</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="120" lower_limit="118" upper_limit="122"/>
                    <measurement group_id="O2" value="115" lower_limit="113" upper_limit="117"/>
                    <measurement group_id="O3" value="121" lower_limit="117" upper_limit="125"/>
                    <measurement group_id="O4" value="114" lower_limit="112" upper_limit="116"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Thigh Subcutaneous Fat</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Main effects analyses with Diet vs. No Diet.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Thigh Subcutaneous Fat</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.26</p_value>
            <p_value_desc>Main effects analysis for Exercise vs. No Exercise.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Thigh Skeletal Muscle</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.001</p_value>
            <p_value_desc>Main effects analyses with Diet vs. No Diet.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Thigh Skeletal Muscle</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.26</p_value>
            <p_value_desc>Main effects analysis of Exercise vs. No Exercise.</p_value_desc>
            <method>ANCOVA</method>
            <method_desc>Least Square Mean at follow up adjusted for the following covariates: baseline measure of the outcome measure, sex, and beta blocker usage.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>20 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Exercise Training</title>
          <description>Based on initial evaluations and the stress testing results, (HR(heart rate), VO2(maximal volume of oxygen that the body can deliver to the working muscles per minute), RPE(rate perceived exertion) an individualized exercise prescription will be developed for each subject.
Exercise: walking, treadmill and bicycle exercise</description>
        </group>
        <group group_id="E2">
          <title>Dietary Intervention</title>
          <description>A hypocaloric diet will be developed to achieve a 2800 kcal/week deficit, which should produce about 0.4 kg (1 lb) weight loss per week.
Dietary Intervention: Subjects will be provided meals and instructions for individual food selections.</description>
        </group>
        <group group_id="E3">
          <title>Attention Control</title>
          <description>Attention control participants will be provided a counseling session regarding general health education at baseline and will be contacted by staff via telephone every 2 weeks to discuss general health status.
Attention Control: control group- continue their previously randomized life style</description>
        </group>
        <group group_id="E4">
          <title>Diet and Exercise</title>
          <description>The diet and exercise group is a combination of the two groups previously described.
Exercise: walking, treadmill and bicycle exercise
Diet and exercise: Combination of the exercise and diet group as previously described.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Leg edema</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" events="2" subjects_affected="1" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Heart failure exacerbation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" events="3" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Stress fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
              <event>
                <sub_title>Tendon tear</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="24"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="25"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="25"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dalane W. Kitzman, M.D.</name_or_title>
      <organization>Wake Forest School of Medicine</organization>
      <phone>336-716-3274</phone>
      <email>dkitzman@wakehealth.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

